Skip to main content

Peer Review reports

From: Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors

Original Submission
9 Apr 2012 Submitted Original manuscript
12 Apr 2012 Author responded Author comments - Ruth Chiquet-Ehrismann
Resubmission - Version 2
12 Apr 2012 Submitted Manuscript version 2
12 Apr 2012 Author responded Author comments - Ruth Chiquet-Ehrismann
Resubmission - Version 3
12 Apr 2012 Submitted Manuscript version 3
12 Apr 2012 Author responded Author comments - Ruth Chiquet-Ehrismann
Resubmission - Version 4
12 Apr 2012 Submitted Manuscript version 4
11 Jun 2012 Reviewed Reviewer Report - David Guttery
20 Jun 2012 Reviewed Reviewer Report - Petra Richter
10 Aug 2012 Author responded Author comments - Ruth Chiquet-Ehrismann
Resubmission - Version 5
10 Aug 2012 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
15 Aug 2012 Author responded Author comments - Ruth Chiquet-Ehrismann
16 Aug 2012 Reviewed Reviewer Report - David Guttery
Resubmission - Version 10
15 Aug 2012 Submitted Manuscript version 10
Publishing
27 Aug 2012 Editorially accepted
4 Sep 2012 Article published 10.1186/1472-6890-12-14

You can find further information about peer review here.

Back to article page